Potential of microRNAs for cancer diagnostics, prognostication and therapy

被引：70
作者：
Garzon, Ramiro [1 ]
Marcucci, Guido [1 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Dept Med, Div Hematol, Columbus, OH 43210 USA
来源：
CURRENT OPINION IN ONCOLOGY | 2012年 / 24卷 / 06期
关键词：
diagnosis; microRNA; prognosis; therapeutics; SMALL-MOLECULE INHIBITORS; ACUTE MYELOID-LEUKEMIA; TISSUE; EXPRESSION; IDENTIFICATION; BIOMARKERS; PROFILES; IDENTIFY; PLASMA; RNAS;
D O I：
10.1097/CCO.0b013e328358522c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of review MicroRNAs (miRNAs) are small regulatory RNAs that are frequently deregulated in cancer and have shown great potential as biomarkers for cancer diagnosis and prognostication. Recent studies also support great promise in targeting miRNAs in cancer. Recent findings In this review, we will discuss the most important aspects about the use of miRNAs for the diagnosis, prognosis and therapy in cancer, including current pitfalls and future directions. Summary The definitive establishment of miRNAs as biomarkers and as therapeutic targets in cancer will likely have a profound impact on clinical practice and research.
引用
收藏
页码：655 / 659
页数：5
相关论文
共 38 条
  • [1] Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
    Blum, William
    Schwind, Sebastian
    Tarighat, Somayeh S.
    Geyer, Susan
    Eisfeld, Ann-Kathrin
    Whitman, Susan
    Walker, Alison
    Klisovic, Rebecca
    Byrd, John C.
    Santhanam, Ramasamy
    Wang, Hongyan
    Curfman, John P.
    Devine, Steven M.
    Jacob, Samson
    Garr, Celia
    Kefauver, Cheryl
    Perrotti, Danilo
    Chan, Kenneth K.
    Bloomfield, Clara D.
    Caligiuri, Michael A.
    Grever, Michael R.
    Garzon, Ramiro
    Marcucci, Guido
    [J]. BLOOD, 2012, 119 (25) : 6025 - 6031
  • [2] Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
    Blum, William
    Garzon, Ramiro
    Klisovic, Rebecca B.
    Schwind, Sebastian
    Walker, Alison
    Geyer, Susan
    Liu, Shujun
    Havelange, Violaine
    Becker, Heiko
    Schaaf, Larry
    Mickle, Jon
    Devine, Hollie
    Kefauver, Cheryl
    Devine, Steven M.
    Chan, Kenneth K.
    Heerema, Nyla A.
    Bloomfield, Clara D.
    Grever, Michael R.
    Byrd, John C.
    Villalona-Calero, Miguel
    Croce, Carlo M.
    Marcucci, Guido
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (16) : 7473 - 7478
  • [3] MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
    Boeri, Mattia
    Verri, Carla
    Conte, Davide
    Roz, Luca
    Modena, Piergiorgio
    Facchinetti, Federica
    Calabro, Elisa
    Croce, Carlo M.
    Pastorino, Ugo
    Sozzi, Gabriella
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (09) : 3713 - 3718
  • [4] Serum microRNAs as non-invasive biomarkers for cancer
    Brase, Jan C.
    Wuttig, Daniela
    Kuner, Ruprecht
    Sueltmann, Holger
    [J]. MOLECULAR CANCER, 2010, 9
  • [5] Changes in circulating microRNA levels associated with prostate cancer
    Bryant, R. J.
    Pawlowski, T.
    Catto, J. W. F.
    Marsden, G.
    Vessella, R. L.
    Rhees, B.
    Kuslich, C.
    Visakorpi, T.
    Hamdy, F. C.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (04) : 768 - 774
  • [6] Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
    Cheng, Hanyin
    Zhang, Lina
    Cogdell, David E.
    Zheng, Hong
    Schetter, Aaron J.
    Nykter, Matti
    Harris, Curtis C.
    Chen, Kexin
    Hamilton, Stanley R.
    Zhang, Wei
    [J]. PLOS ONE, 2011, 6 (03):
  • [7] High-Throughput Luciferase Reporter Assay for Small-Molecule Inhibitors of MicroRNA Function
    Connelly, Colleen M.
    Thomas, Meryl
    Deiters, Alexander
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (06) : 822 - 828
  • [8] MicroRNAs in body fluids-the mix of hormones and biomarkers
    Cortez, Maria Angelica
    Bueso-Ramos, Carlos
    Ferdin, Jana
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Calin, George A.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (08) : 467 - 477
  • [9] Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver
    Elmen, Joacim
    Lindow, Morten
    Silahtaroglu, Asli
    Bak, Mads
    Christensen, Mette
    Lind-Thomsen, Allan
    Hedtjarn, Maj
    Hansen, Jens Bo
    Hansen, Henrik Frydenlund
    Straarup, Ellen Marie
    McCullagh, Keith
    Kearney, Phil
    Kauppinen, Sakari
    [J]. NUCLEIC ACIDS RESEARCH, 2008, 36 (04) : 1153 - 1162
  • [10] MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin
    Ferracin, Manuela
    Pedriali, Massimo
    Veronese, Angelo
    Zagatti, Barbara
    Gafa, Roberta
    Magri, Eros
    Lunardi, Maria
    Munerato, Gardenia
    Querzoli, Giulia
    Maestri, Iva
    Ulazzi, Linda
    Nenci, Italo
    Croce, Carlo M.
    Lanza, Giovanni
    Querzoli, Patrizia
    Negrini, Massimo
    [J]. JOURNAL OF PATHOLOGY, 2011, 225 (01) : 43 - 53
1234